LIGAND PHARMACEUTICAL INC (LGNXZ)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 131.31 Million | 196.24 Million | 241.54 Million | 186.41 Million | 120.28 Million | 251.45 Million |
| Cost of Revenue | 43.28 Million | 77.1 Million | 96.27 Million | 56.13 Million | 53.58 Million | 22.12 Million |
| Gross Profit | 88.02 Million | 119.14 Million | 145.27 Million | 130.28 Million | 66.7 Million | 229.32 Million |
| Operating Expenses | 78.2 Million | 106.3 Million | 79.02 Million | 121.55 Million | 72.42 Million | 65.59 Million |
| Selling, General and Administrative Expenses | 52.79 Million | 70.06 Million | 46.79 Million | 64.43 Million | 41.88 Million | 37.73 Million |
| Research and Development Expenses | 25.41 Million | 36.24 Million | 32.22 Million | 57.11 Million | 30.53 Million | 27.86 Million |
| Other Expenses | - | - | 9.56 Million | 53.86 Million | - | - |
| Cost and Expenses | 121.49 Million | 183.4 Million | 175.29 Million | 177.68 Million | 126 Million | 87.72 Million |
| Operating Income | 9.82 Million | 12.83 Million | 66.25 Million | 8.73 Million | -5.72 Million | 163.72 Million |
| Interest Expense | 656 Thousand | 1.79 Million | 19.61 Million | 27.42 Million | 35.74 Million | 48.27 Million |
| Income Tax Expense | 9.84 Million | 41.23 Million | -4.14 Million | -7.55 Million | 167.33 Million | 30 Million |
| Earnings before Tax | 63.66 Million | 36.01 Million | 72.2 Million | -10.53 Million | 796.63 Million | 173.33 Million |
| Net Income | 52.15 Million | -33.36 Million | 57.13 Million | -2.98 Million | 629.3 Million | 143.32 Million |
| Earnings Per Share Basic | 3.02 | -1.98 | 3.44 | -0.18 | 33.13 | 6.77 |
| Earnings Per Share Diluted | 2.94 | -1.98 | 3.31 | -0.18 | 31.85 | 5.96 |
| Weighted Average Shares Outstanding | 17.29 Million | 16.86 Million | 16.62 Million | 16.18 Million | 18.99 Million | 21.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 17.75 Million | 16.86 Million | 17.24 Million | 16.18 Million | 19.75 Million | 24.06 Million |
| Gross Margin | 0.67 | 0.61 | 0.60 | 0.70 | 0.55 | 0.91 |
| EBIT Margin | 0.36 | 0.29 | 0.45 | 0.20 | 0.32 | 0.72 |
| Profit Margin | 0.40 | -0.17 | 0.24 | -0.02 | 5.23 | 0.57 |
| EBITDA | 47.23 Million | 56.23 Million | 133.16 Million | 44.84 Million | 876.11 Million | 238.29 Million |
| Earnings Before Tax Margin | 0.07 | 0.07 | 0.27 | 0.05 | -0.05 | 0.65 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 41.53 Million | 30.97 Million | 28.1 Million | 131.31 Million | 32.86 Million | 26.36 Million |
| Cost of Revenue | 11.16 Million | 11.06 Million | 9.95 Million | 43.28 Million | 11.65 Million | 9.77 Million |
| Gross Profit | 30.36 Million | 19.91 Million | 18.14 Million | 88.02 Million | 21.21 Million | 16.59 Million |
| Operating Expenses | 22.97 Million | 16.92 Million | 21.5 Million | 78.2 Million | 20.25 Million | 18.57 Million |
| Selling, General and Administrative Expenses | 19.12 Million | 10.95 Million | 15.99 Million | - | 14.65 Million | 11.28 Million |
| Research and Development Expenses | 5.35 Million | 5.97 Million | 5.51 Million | - | 5.6 Million | 7.28 Million |
| Other Expenses | 1.5 Million | - | -8.31 Million | -32.6 Million | - | - |
| Cost and Expenses | 34.14 Million | 27.99 Million | 31.45 Million | 121.49 Million | 31.91 Million | 28.34 Million |
| Operating Income | 7.39 Million | 2.98 Million | -3.35 Million | 9.82 Million | 957 Thousand | -1.98 Million |
| Interest Expense | - | 141 Thousand | 131 Thousand | 656 Thousand | 1000.00 | 284 Thousand |
| Income Tax Expense | -13.47 Million | 27.3 Million | -1.09 Million | 9.84 Million | -1.87 Million | 881 Thousand |
| Earnings before Tax | -65.39 Million | 113.44 Million | 17.09 Million | 63.66 Million | -12.14 Million | 3.17 Million |
| Net Income | -51.91 Million | 86.13 Million | 18.18 Million | 52.15 Million | -10.27 Million | 2.29 Million |
| Earnings Per Share Basic | -2.88 | 4.86 | 1.04 | - | -0.59 | 0.13 |
| Earnings Per Share Diluted | -2.88 | 4.75 | 1.03 | - | -0.59 | 0.13 |
| Weighted Average Shares Outstanding | 18.02 Million | 17.73 Million | 17.46 Million | 17.29 Million | 17.38 Million | 17.27 Million |
| Weighted Average Shares Outstanding (Diluted) | 18.02 Million | 18.12 Million | 17.67 Million | 17.75 Million | 17.38 Million | 17.73 Million |
| Gross Margin | 0.73 | 0.64 | 0.65 | 0.67 | 0.65 | 0.63 |
| EBIT Margin | 0.40 | 0.39 | 0.22 | - | 0.30 | 0.29 |
| Profit Margin | -1.25 | 2.78 | 0.65 | 0.40 | -0.31 | 0.09 |
| EBITDA | 16.74 Million | 12.23 Million | 6.07 Million | - | 9.83 Million | 7.52 Million |
| Earnings Before Tax Margin | 0.18 | 0.10 | -0.12 | 0.07 | 0.03 | -0.08 |
ZAIRF
AHELF
ACNI
BKRP
601212
POD